BioCentury
ARTICLE | Clinical News

ARA 290 regulatory update

October 28, 2013 7:00 AM UTC

The European Commission granted Orphan Drug designation to Araim's ARA 290 to treat sarcoidosis. The short tissue protective peptide is in Phase IIb testing for small fiber neuropathy in sarcoidosis p...